Grant Sweep

Consolidated research funding across disease areas and research fields — federal, foundation, state & industry sources in one filterable place.

← Back to opportunities
OpenR03Clinical trial: Optional / allowed

Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional)

National Institutes of Health (NIH) · NIH Institute/Center · PAR-25-155

Source: Grants.gov · View original posting ↗

Award
Up to $50K
Deadline
Oct 19, 2026
Letter of intent
Mechanism
R03
Duration
Expected awards
Funding cycle
Standard NIH dates
Open date
Dec 11, 2024
Total funding
Clinical trial
Optional / allowed
GovernmentHigher educationSmall businessNonprofitForeign entities

Description

The purpose of this NOFO is to enhance the capability of NCATS CTSA Program KL2 scholars and recipients of re-entry supplements supported by the CTSA Program to conduct research as they complete the transition to fully independent academic translational scientists. These R03 grants will support different clinical and translational science research projects, including pilot and feasibility studies; secondary data analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. Research proposed in the R03 application may or may not include patient-oriented research. The R03 is, therefore, intended to support research projects that can be carried out in a short period of time with limited resources and that provide preliminary data to support submission of a subsequent R01, or equivalent, application.

Data notes: administering NIH institute could not be identified from the opportunity number.